Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
873
datasets available to search
ShareScore release 0.9.0
Dataset results
873 results for “ligands”
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT05029999. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand
ClinicalTrials.gov study NCT03089918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (P
ClinicalTrials.gov study NCT04165083. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (
ClinicalTrials.gov study NCT06345729. IPD Sharing: YES. Countries: 27. Publications: 0.
Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in
ClinicalTrials.gov study NCT06405230. IPD Sharing: YES. Countries: 1. Publications: 0.
A Validation and Dosimetry Study of GSK2634673F PET Ligand
ClinicalTrials.gov study NCT02052297. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT05830097. IPD Sharing: NO. Countries: 2. Publications: 0.
Positron-Emission Tomography With Vesicular Monoamine Transporter Ligand ([18F]-DTBZ) In Healthy Elderly And Young Subjects
ClinicalTrials.gov study NCT01838785. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid
ClinicalTrials.gov study NCT00692705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis
ClinicalTrials.gov study NCT00309660. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT06472076. IPD Sharing: YES. Countries: 21. Publications: 0.
Effect of Anesthesia on Expression of Programmed Death-1 and Programmed Death-1 Ligand in Breast Cancer
ClinicalTrials.gov study NCT04657237. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279
ClinicalTrials.gov study NCT02169973. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant
ClinicalTrials.gov study NCT00089453. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens
ClinicalTrials.gov study NCT03092739. IPD Sharing: NO. Countries: 6. Publications: 0.
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
ClinicalTrials.gov study NCT00078520. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC
ClinicalTrials.gov study NCT03478488. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
ClinicalTrials.gov study NCT00328887. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
ClinicalTrials.gov study NCT06898957. IPD Sharing: YES. Countries: 10. Publications: 0.
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
ClinicalTrials.gov study NCT00058799. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.